We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATAQ.U
301
DELISTED
Altimar Acquisition Corp III Units
ATAQ.U
$1.74M 0.05%
193,403
NFNT
302
DELISTED
Infinite Acquisition Corp.
NFNT
$1.72M 0.05%
+167,756
New +$1.7M
FSRX
303
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$1.72M 0.05%
171,108
BIOS
304
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
$1.69M 0.05%
+164,243
New +$1.67M
SCAQ
305
DELISTED
Stratim Cloud Acquisition Corp. Class A Common Stock
SCAQ
$1.69M 0.05%
+167,500
New +$1.66M
SCOBU
306
DELISTED
ScION Tech Growth II Units
SCOBU
$1.64M 0.05%
162,400
CBRG
307
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
$1.63M 0.04%
158,400
+38,050
+32% +$387K
TRCA
308
DELISTED
Twin Ridge Capital Acquisition Corp.
TRCA
$1.57M 0.04%
+155,655
New +$1.56M
KAIR
309
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$1.56M 0.04%
155,050
ENTFU
310
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Unit
ENTFU
$1.54M 0.04%
150,000
XFINU
311
DELISTED
ExcelFin Acquisition Corp Unit
XFINU
$1.53M 0.04%
150,000
AEAEU
312
DELISTED
AltEnergy Acquisition Corp Unit
AEAEU
$1.53M 0.04%
150,000
HMAC
313
DELISTED
Hainan Manaslu Acquisition Corp. Ordinary shares
HMAC
$1.52M 0.04%
+150,000
New +$1.51M
IPVF
314
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
$1.51M 0.04%
149,985
VBOCU
315
DELISTED
Viscogliosi Brothers Acquisition Corp Unit
VBOCU
$1.51M 0.04%
150,000
ESM.U
316
DELISTED
ESM Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ESM.U
$1.51M 0.04%
150,000
FSNB
317
DELISTED
Fusion Acquisition Corp. II
FSNB
$1.51M 0.04%
+150,000
New +$1.49M
NBSTU
318
DELISTED
Newbury Street Acquisition Corporation Units
NBSTU
$1.5M 0.04%
150,000
ZLS
319
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$1.5M 0.04%
+150,000
New +$1.49M
APXI
320
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
$1.49M 0.04%
145,747
SCPL
321
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$1.46M 0.04%
90,967
-154,884
-63% -$2.25M
SVFAU
322
DELISTED
SVF Investment Corp. Unit
SVFAU
$1.43M 0.04%
141,700
BWAQ
323
DELISTED
Blue World Acquisition Corporation Class A Ordinary Shares
BWAQ
$1.41M 0.04%
+138,100
New +$1.4M
YTPG
324
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$1.38M 0.04%
140,146
CNGL
325
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
$1.38M 0.04%
+134,850
New +$1.37M

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.